BCL2 and breast cancer: Treatment of human breast cancer (MCF-7) cells with Cladosporol A decreased ΔΨm, upregulated Bax expression and downregulated Bcl-2 levels in a concentration-dependent manner, thereby increasing the ratio of Bax/Bcl-2 protein levels (Fig. 10).